Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y9EU
|
|||
| Former ID |
DNC008449
|
|||
| Drug Name |
4-heptyl-N-(quinolin-3-yl)benzamide
|
|||
| Synonyms |
CHEMBL406860; AC1MYO1K; SCHEMBL846864; 4-heptyl-N-quinolin-3-ylbenzamide; BDBM50376279
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H26N2O
|
|||
| Canonical SMILES |
CCCCCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2
|
|||
| InChI |
1S/C23H26N2O/c1-2-3-4-5-6-9-18-12-14-19(15-13-18)23(26)25-21-16-20-10-7-8-11-22(20)24-17-21/h7-8,10-17H,2-6,9H2,1H3,(H,25,26)
|
|||
| InChIKey |
VJFYODCLTPGLMR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Inflammatory mediator regulation of TRP channels | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
| Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
| Reactome | TRP channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1). Bioorg Med Chem Lett. 2008 Apr 15;18(8):2730-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.